Please try another search
TaiRx Inc is a Taiwan-based company mainly engaged in the development and research of new drugs. The Company primarily focus on the research and development of cancer treatment drugs and sepsis adjuvant therapy drugs. The Company's main products include CVM-1118, Rexis, Zelnite, TRX-NOC, TRX-920, TRX-711, TRX-105 and others. CVM-1118 and Rexis are in clinical trials, and Zelnite drugs are sold to domestic medical institutions at all levels through distributors.
Name | Age | Since | Title |
---|---|---|---|
Sheng-Chu Kuo | - | - | Director |
Jang-Yang Chang | - | - | Member of Scientific Advisory Committee |
Andrew Lin | - | - | Chairman of The Board |
Sarah Lee | - | - | Director |
Lucas Lin | - | - | Independent Director |
Yi-Wen Chu | - | - | Senior VP & Director |
Mary J.C. Hendrix | - | - | Member of Scientific Advisory Committee |
Tian-Shung Wu | - | - | Director |
Hsien-Shou Kuo | - | - | Independent Director |
Chia Hsiang Chang | - | - | Independent Director |
Harry M. Olson | - | - | Member of Scientific Advisory Committee |
Frank Shen | - | - | Director |
Chien Du-Shieng | - | - | Co-Founder, President, CEO & Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review